SKI Market

A+| A| A-|

Indian Indices

Sensex

74,360.01 13.84
( 0.02%)

Global Indices

Nasdaq

50,746.98 -581.81
(-1.13%)

Dow Jones

7,576.82 -53.96
(-0.71%)

Hang Seng

67,369.16 -1,032.97
(-1.51%)

Nikkei 225

10,347.89 15.59
(0.15%)

Forex

USD-INR

95.24 0.16
(0.17%)

EUR-INR

110.83 0.16
(0.15%)

GBP-INR

128.25 0.32
(0.25%)

JPY-INR

0.60 0.00
(0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

338.0498657

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

38.67

36613.01

EPS(TTM)

Face Value()

Div & Yield %

75.78

Back

alumeco india extrusion ltd

NCL Research and Financial Services reports standalone net loss of Rs 5.59 crore in the March 2026 quarter

May 30,2026

Net loss of NCL Research and Financial Services reported to Rs 5.59 crore in the quarter ended March 2026 as against net profit of Rs 0.10 crore during the previous quarter ended March 2025. Sales declined 86.14% to Rs 0.28 crore in the quarter ended March 2026 as against Rs 2.02 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 2.60 crore in the year ended March 2026 as against net loss of Rs 1.36 crore during the previous year ended March 2025. Sales declined 27.78% to Rs 6.16 crore in the year ended March 2026 as against Rs 8.53 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	0.28	2.02	-86	6.16	8.53	-28
OPM %	-2250.00	37.62	-	-44.81	-8.68	-
PBDT	-6.85	0.14	PL	-2.78	-0.60	-363
PBT	-6.86	0.12	PL	-2.82	-0.66	-327
NP	-5.59	0.10	PL	-2.60	-1.36	-91

74,360.01 13.84 ( 0.02%)

50,746.98 -581.81 (-1.13%)

7,576.82 -53.96 (-0.71%)

67,369.16 -1,032.97 (-1.51%)

10,347.89 15.59 (0.15%)

95.24 0.16 (0.17%)

110.83 0.16 (0.15%)

128.25 0.32 (0.25%)

0.60 0.00 (0.02%)